| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.47 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |